Setyo Gundi Pramudo

Setyo Gundi Pramudo

Auto-generated profile, based on publicly available information

Setyo Gundi Pramudo

Department of Internal Medicine, Faculty of Medicine, Universitas Diponegoro, Semarang, Indonesia

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 June 2022 in Patient Preference and Adherence
Verified
Journal Article
Open access
PDF file
AUAras Utami
Aras Utami
AMAni Margawati
Ani Margawati
DPDodik Pramono
Dodik Pramono
ANArwinda Nugraheni
Arwinda Nugraheni
SPSetyo Gundi Pramudo
Setyo Gundi Pramudo
Purpose: The Coronavirus disease (COVID-19) vaccination program has been rolled out to address the pandemic. However, the COVID-19 vaccination coverage rate in Indonesia, especially in Central Java, is low. The study aimed to identify COVID-19 vaccine acceptance and to determine the factors associated with COVID-19 vaccine hesitancy. Participants and Methods: A cross-sectional study was conducted from September to October 2021. A self-reported questionnaire was distributed to participants aged ≥ 18 years and living permanently in the area of study by the multistage sampling technique. Bivariate and multivariate analyses were performed to determine the association. All statistical tests were significantly considered if the p-value < 0.05 at 95% confidence interval (CI). Results: A total of 500 participants were eligible, with the age ranging from 18 to 76 years old. COVID-19 vaccine acceptance rate was 93.6%. In the multivariate logistic regression analysis, we found that the elderly (aOR=5.231; 95% CI=1.891– 14.468), having comorbidity (aOR=4.808; 95% CI=1.975– 11.706), not being exposed to information (aOR=7.039; 95% CI=2.072– 23.908), not believing in the vaccine halalness (OR=3.802; 95% CI=1.272– 11.364), not believing that vaccines could prevent the COVID-19 infection (OR=4.964; 95% CI=1.970– 12.507), and having vaccination-related mild-moderate anxiety (OR=14.169; 95% CI=2.405– 83.474) were more likely to have vaccine hesitancy (p< 0.05). Place of residence, education level, belief that the vaccine could prevent the severe symptoms of COVID-19, and knowledge were significantly related to the vaccine acceptance in the bivariate analysis (p< 0.05), but they were no longer significant in the multivariate (p> 0.05). Conclusion: A high acceptance rate of the COVID-19 vaccine was found in this study. However, vaccine hesitancy is a major public health concern for attaining herd immunity and reducing the risk of case mortality. These findings could be the strategic focus for the government to improve COVID-19 vaccination coverage.

11 May 2020 in Jurnal Kedokteran Diponegoro (Diponegoro Medical Journal)
Verified
Journal Article
Open access
PDF file
IAIndra Adhim Karunia Aji
Indra Adhim Karunia Aji
ASAndreas Arie Setiawan
Andreas Arie Setiawan
AAAriosta Ariosta
Ariosta Ariosta
SPSetyo Gundi Pramudo
Setyo Gundi Pramudo
Introduction. Populations with high BMI are at risk for cardiovascular disease because these populations usually have high levels of fat in the body. In contrast, there are several studies that prove that body weight below normal BMI also increases cardiovascular disease risk and death. The aim of this study was to determine the impact of BMI on mortality rates of in-hospital patients with acute myocardial infarction at dr. Kariadi Hospital. Methods. This research is a retrospective analytic observational study with cross sectional design. The sample of this study was acute myocardial infarction patients who were undergoing treatment at the RSUP dr. Kariadi between January 2013 - December 2018 complete data on body weight, height, and status of death or survival. Data comparisons were made using fisher exact test with statistical significant p value was less than 0.05. Results. Statistical analysis using fisher exact test showed association between body mass index and mortality rate is not significant (p = 0,258). Age is the only one confounding variable that showed significant association with mortality rate (p =0,032). Relative risk of age is 1.8 with a cutoff at 60 years. Conclusions. Body mass index (BMI) did not have a significant impact on the mortality rate of AMI in-hospital patients at dr. Kariadi Hospital. Keywords: body mass index, acute myocardial infarction, mortality

1 February 2024 in The Open Public Health Journal
Verified
Journal Article
Open access
PDF file
NFNur Farhanah
Nur Farhanah
SPSetyo Gundi Pramudo
Setyo Gundi Pramudo
KHKhoulah Hanifah
Khoulah Hanifah
YNYetty Movieta Nency
Yetty Movieta Nency
RHRebriarina Hapsari
Rebriarina Hapsari
NMNani Maharani
Nani Maharani
Introduction: We conducted a Phase I SARS-CoV-2 vaccine trial in March 2022. During the screening, we identified a significant number of asymptomatic COVID-19 cases among the candidate participants. We aimed to highlight the clinical characteristics among these asymptomatic individuals as compared to subjects negative for SARS-CoV-2. Methods: This observational study was conducted during participant screening for a Phase I SARS-CoV-2 vaccine trial in Jepara and Mranggen districts in Central Java, Semarang, Indonesia. Participants who reported no symptoms associated with COVID-19, confirmed by physical examinations, were included. Data on laboratory markers were documented. An asymptomatic case was defined as showing no clinical symptoms and signs of SARS-CoV-2 infection with a positive SARS-CoV-2 RT-PCR result. Individuals who tested negative for SARS-CoV-2 were included for comparison. A chi-square test was employed to assess the differences between the two groups, with a p-value 0.05) among individuals with positive and negative SARS-CoV-2. Conclusion: In our vaccine trial screening phase, almost half were ineligible due to having asymptomatic SARS-CoV-2 infections. In addition, it is necessary that people with asymptomatic COVID-19 infection still need to be concerned because they have the same transmission potential.

25 August 2022 in Journal of Biomedicine and Translational Research
Verified
Journal Article
Open access
PDF file
DRDwi Retnoningrum
Dwi Retnoningrum
MSMuchlis Achsan Udji Sofro
Muchlis Achsan Udji Sofro
SPSetyo Gundi Pramudo
Setyo Gundi Pramudo
SWSatrio Adi Wicaksono
Satrio Adi Wicaksono
ADAndaru Dahesihdewi
Andaru Dahesihdewi
Background: Sepsis is a condition in systemic infection associated with organ dysfunction. Interleukin-17 is a pro-inflammatory cytokine produced by Th-17 cells. C- reactive protein and neutrophil-lymphocyte ratio (NLR) have been widely used as markers of inflammation. The relationship between IL-17 as a proinflammatory cytokine with CRP and NLR has not been reported. Objective: This study aims to prove the correlation between IL-17 with CRP and NLR in septic patients. Methods: Analytical observational study with a cross-sectional approach was carried out on 40 septic patients in July–December 2020. IL-17 levels were obtained by the ELISA method while CRP levels were obtained using the immunoturbidimetric method. NLR was the result of dividing the absolute number of neutrophils and lymphocytes from the automatic hematology analyzer. Correlation between variables was performed using Spearman correlation test. Results: The median levels of IL-17, CPR, and NLR were 363.55 (11.4-1695.80) pg/mL, 13.25 (0.43-53.87) mg/L, and 12.00 (2.26–48.5), respectively. The Spearman correlation test between IL-17 levels and CRP obtained p = 0.019, r = 0.37, and NLR p = 0.425, r = 0.13. Conclusion: There is a weak positive correlation between IL-17 levels and CRP in septic patients. There is no correlation between IL-17 levels and NLR in septic patients.

31 July 2023 in JAI (Jurnal Anestesiologi Indonesia)
Verified
Journal Article
Open access
PDF file
DRDwi Retnoningrum
Dwi Retnoningrum
SPSetyo Gundi Pramudo
Setyo Gundi Pramudo
TNTaufik Eko Nugroho
Taufik Eko Nugroho
QQQonita Nur Qolby
Qonita Nur Qolby
Background: Coronavirus disease 19 (COVID-19) has become pandemic in the world with a board spectrum of clinical presentation. Secondary infection of methicillin-resistant staphylococcus aureus (MRSA) affects morbidity and mortality in patients with COVID-19.Case: We reported two COVID-19 patients with MRSA hospitalized in intensive care unit (ICU) of Diponegoro National Hospital. The first patient was 61-year-old woman that was referred from another hospital with confirmed COVID-19 infection and acute respiratory distress syndrome and had been intubated. Diabetes mellitus and hypertension were known as comorbid. On day 4 of treatment in ICU, blood culture results showed MRSA infection and antibiotic therapy was replaced with Vancomycin. The patient had clinical improvement and was discharge from the hospital on the 36th day of treatment. The second one was 51-year-old woman admitted with probable COVID-19, type II Diabetes Mellitus and hypertension. On day 9th the patient was transferred to ICU because of respiratory failure, blood culture on day 15th show a result of MRSA and antibiotic therapy was replaced with vancomycin. She declined intubation procedures and died on day 20.Discussion: Antibiotic resistance has become one of the important things in infection management in the world. Multidrug-resistant bacteria (MDR) cause treatment failure which increases the risk of death and cost. MRSA has become one of the most important MDR bacteria during the last decade causing severe infections in health facilities. Complications of bacterial infection in COVID-19, especially bacteremia increases the severity and mortality of severe patients.Conclusion: Coinfection of MRSA in COVID-19 patients can affect the clinical outcome. One of important risk factor is history or prolonged hospitalized. Other factors are comorbidity of the patient and appropriate therapy is needed to reduce mortality in Intensive Care Unit.

27 July 2026 in INDONESIAN JOURNAL OF CLINICAL PATHOLOGY AND MEDICAL LABORATORY
Verified
Journal Article
Open access
PDF file
DRDwi Retnoningrum
Dwi Retnoningrum
MHMeita Hendrianingtyas
Meita Hendrianingtyas
RHRebriarina Hapsari
Rebriarina Hapsari
SPSetyo Gundi Pramudo
Setyo Gundi Pramudo
ELEdward Kurnia Setiawan Limijadi
Edward Kurnia Setiawan Limijadi
Coronavirus disease-19 (COVID-19) is an infection that causes physical and psychological stress. Cortisol and prolactin are hormones that have been studied in association with infectious states. Viral infections trigger the production of acute-phase proteins and antibodies essential for viral elimination. This study aimed to prove the correlation between stress hormone levels and inflammatory markers and antibodies in COVID-19 patients. A cross-sectional approach was employed in this study, with a target population of patients with moderate-to-severe COVID-19. Cortisol, prolactin, and specific antibodies were quantified via ELISA, while CRP and procalcitonin levels were measured using immunoturbidimetric and immunofluorescence assays. Additionally, anti-SARS-CoV-2 antibodies were evaluated using the ECLIA principle. Statistical analysis was performed using the Spearman rank correlation test. Fifty-six subjects were included in this study. The study found correlations between cortisol and prolactin levels and CRP (p=0.007, r=0.357; p=0.132, r=0.204) and procalcitonin (p=0.006, r=0.365; p=0.315, r=0.137). The correlations between cortisol and prolactin levels and IgM were p=0.163, r=-0.189; and p=0.299, r=-0.141. The correlations between cortisol and prolactin levels and IgG were p=0.017, r=-0.317, and p=0.207, r=-0.171. There is a weak positive correlation between cortisol levels and CRP and procalcitonin levels. There is a weak negative correlation between cortisol levels and anti-SARS-CoV-2 IgG.